{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:30:43Z","timestamp":1787758243689,"version":"build-2784847793"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Ethambutol (EMB) is one of the first-line drugs used for treating tuberculosis. Vision loss due to optic nerve toxicity is a well-known potential side effect of the drug. Our aim was to evaluate the clinical features and visual outcomes of patients with EMB optic neuropathy (EON).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective, observational, single-center study of all patients who were diagnosed to have EON during January 2017\u2013December 2019 was done. All these patients were screened in the Department of Neuro-ophthalmology at a referral tertiary eye care institution in India. Clinical features, visual outcomes, and neuroimaging findings of these patients were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Two hundred and fifty-six eyes of 128 patients were included. Of these, 73 were male and 55 were female. Mean age was 50.55 \u00b1 15 years. Mean visual acuity at presentation was 1.12 \u00b1 0.45 logarithm of the minimum angle of resolution (logMAR). One hundred and forty three eyes had normal optic disk on presentation, 111 had disk pallor, and two eyes had disk edema. The most common field defect was central\/paracentral scotoma (26.2%) followed by temporal defects (24.6%). Magnetic resonance imaging (MRI) brain and orbit showed optic nerve signals in 19.6% and chiasmal signals in 5.2%. At the final follow-up, a \u22652-line vision improvement was noted in 161 eyes (62.9%), which was statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Multiple prognostic factors were analyzed to predict the visual recovery of EON. We observed that patients presenting with visual acuity worse than 6\/60 had poor visual outcome and long duration of follow-up showed better visual recovery, proving the possibility of a gradual recovery pattern of EON. Interestingly, we found in our study that the chances of favorable visual outcome were directly proportionate to early diagnosis and cessation of EMB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_2996_21","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T05:38:02Z","timestamp":1661751482000},"page":"3388-3392","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Visual outcomes of toxic optic neuropathy secondary to Ethambutol: A retrospective observational study from India, an endemic country"],"prefix":"10.4103","volume":"70","author":[{"given":"Selvakumar","family":"Ambika","sequence":"first","affiliation":[{"name":"Department of Neuro-Ophthalmology, Sankara Nethralaya- A Unit of Medical Research Foundation, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Padma","family":"Lakshmi","sequence":"additional","affiliation":[{"name":"Department of Neuro-Ophthalmology, Sankara Nethralaya- A Unit of Medical Research Foundation, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Gopal","sequence":"additional","affiliation":[{"name":"Department of Neuro-Ophthalmology, Sankara Nethralaya- A Unit of Medical Research Foundation, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olma V","family":"Noronha","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sankara Nethralaya- A Unit of Medical Research Foundation, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"B1-20240828","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archopht.1962.00960020566009","article-title":"Ocular manifestations of ethambutol, toxic amblyopia after administration of an experimental antituberculous drug","volume":"67","author":"Carr","year":"1962","journal-title":"Arch Ophthalmol"},{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/ICU.0000000000000416","article-title":"Ethambutol optic neuropathy","volume":"28","author":"Chamberlain","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/WNO.0b013e31818f138f","article-title":"Ethambutol optic neuropathy:How we can prevent 100,000 new cases of blindness each year","volume":"28","author":"Sadun","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"B4-20240828","first-page":"54","article-title":"The Inosrg. ethambutol optic neuropathy:Vigilance and screening, the keys to prevent blindness with the revised anti-tuberculous therapy regimen","volume":"69","author":"Saxena","year":"2021","journal-title":"J Assoc Physicians India"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bjophthalmol-2012-301870","article-title":"Ethambutol-induced optic neuropathy:A nationwide population-based study from Taiwan","volume":"96","author":"Chen","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10792-009-9293-z","article-title":"Risk factors for ethambutol optic toxicity","volume":"30","author":"Talbert Estlin","year":"2010","journal-title":"Int Ophthalmol"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4065\/78.11.1409","article-title":"Ocular ethambutol toxicity","volume":"78","author":"Melamud","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"B9-20240828","first-page":"428","article-title":"Ocular toxicity from ethambutol:A review of 4 cases and recommended precautions","volume":"111","author":"Sivakumaran","year":"1998","journal-title":"NZ Med J"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/WNO.0b013e31818e3c6b","article-title":"Incidence and clinical features of ethambutol-induced optic neuropathy in Korea","volume":"28","author":"Lee","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.kjms.2015.05.004","article-title":"Incidence and prognostic factor of ethambutol-related optic neuropathy:10-year experience in southern Taiwan","volume":"31","author":"Chen","year":"2015","journal-title":"Kaohsiung J Med Sci"},{"key":"B12-20240828","first-page":"15","article-title":"Ocular ethambutol toxicity:Is it reversible?","volume":"13","author":"Kumar","year":"1993","journal-title":"J Clin Neuroophthalmol"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/jop.1995.11.411","article-title":"Visual function in recovered ethambutol optic neuropathy","volume":"11","author":"Woung","year":"1995","journal-title":"J Ocular Pharmacol Ther"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/WNO.0b013e3182901969","article-title":"Drug-related mitochondrial optic neuropathies","volume":"33","author":"Wang","year":"2013","journal-title":"J Neuroophthalmol"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/aos.12515","article-title":"Toxic optic neuropathies","volume":"93","author":"Grzybowski","year":"2015","journal-title":"Acta Opthhalmol"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archneur.1983.04050090081014","article-title":"Visual evoked potentials in the detection of subclinical optic toxic effects secondary to ethambutol","volume":"40","author":"Yiannikas","year":"1983","journal-title":"Arch Neurol"},{"key":"B17-20240828","first-page":"847","article-title":"Visual evoked responses in ethambutol induced optic neuritis","volume":"45","author":"Srivastava","year":"1997","journal-title":"J Assoc Physicians India"},{"key":"B18-20240828","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/bjo.2008.148502","article-title":"Prospective evaluation of visual function for early detection of ethambutol toxicity","volume":"93","author":"Menon","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"B19-20240828","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/15569527.2015.1079784","article-title":"Visual function test for early detection of ethambutol induced ocular toxicity at the subclinical level","volume":"35","author":"Kim","year":"2016","journal-title":"Cutan Ocul Toxicol"},{"key":"B20-20240828","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/WNO.0000000000000095","article-title":"Optic chiasm involvement on MRI with ethambutol-induced bitemporal hemianopia","volume":"34","author":"Osaguona","year":"2014","journal-title":"J Neuroophthalmol"},{"key":"B21-20240828","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/WNO.0000000000000141","article-title":"Optochiasmatic and peripheral neuropathy due to ehtambutol overtreatment","volume":"34","author":"Geyer","year":"2014","journal-title":"J Neuroophthalmol"},{"key":"B22-20240828","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/jop.1997.13.473","article-title":"Reversibility of ethambutol optic neuropathy","volume":"13","author":"Tsai","year":"1997","journal-title":"J Ocul Pharmacol Ther"},{"key":"B23-20240828","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.taap.2008.11.006","article-title":"Ethambutol-induced toxicity is mediated by zinc and lysosomal membrane permeabilization in cultured retinal cells","volume":"235","author":"Chung","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"B24-20240828","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0732-8893(97)00217-4","article-title":"The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy","volume":"30","author":"Kozak","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B25-20240828","first-page":"80","article-title":"The incidence of optic neuropathy in 84 patients treated with ethambutol","volume":"12","author":"De Palma","year":"1989","journal-title":"Metab Pediatr Syst Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2996_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:11:11Z","timestamp":1787757071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2996_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2996_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"2021-11-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}